Abound Wealth Management Pro Mis Neurosciences Inc. Transaction History
Abound Wealth Management
- $300 Billion
- Q1 2025
A detailed history of Abound Wealth Management transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Abound Wealth Management holds 1 shares of PMN stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PMN
# of Institutions
20Shares Held
9.75MCall Options Held
0Put Options Held
0-
Great Point Partners LLC Greenwich, CT2.65MShares$1.56 Million1.62% of portfolio
-
Armistice Capital, LLC New York, NY2.51MShares$1.48 Million0.03% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.93MShares$1.14 Million0.37% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY1.59MShares$939,6361.68% of portfolio
-
Altium Capital Management LP New York, NY581KShares$343,0230.18% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...